Found: 85
Select item for more details and to access through your institution.
Models to identify treatments for the acute and persistent effects of seizure-inducing chemical threat agents.
- Published in:
- Annals of the New York Academy of Sciences, 2016, v. 1378, n. 1, p. 124, doi. 10.1111/nyas.13137
- By:
- Publication type:
- Article
Voltage-gated potassium channels as therapeutic targets.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Endothelial KCa channels: Novel targets to reduce atherosclerosis-driven vascular dysfunction.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 1, doi. 10.3389/fphar.2023.1151244
- By:
- Publication type:
- Article
Apamin structure and pharmacology revisited.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.977440
- By:
- Publication type:
- Article
Editorial: Venoms, animal and microbial toxins, volume II.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.973628
- By:
- Publication type:
- Article
Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Immune regulatory roles for Kv1.3 channels in Microglia in Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078851
- By:
- Publication type:
- Article
Identification of Kv1.3 potassium channel interacting proteins in mammalian cells.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.058672
- By:
- Publication type:
- Article
O5‐05‐05: REPURPOSING THE KCA3.1 INHIBITOR SENICAPOC AS A MICROGLIA‐TARGETED THERAPEUTIC CANDIDATE FOR ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1656, doi. 10.1016/j.jalz.2018.06.3023
- By:
- Publication type:
- Article
The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Biophysical basis for Kv1.3 regulation of membrane potential changes induced by P2X4‐mediated calcium entry in microglia.
- Published in:
- Glia, 2020, v. 68, n. 11, p. 2377, doi. 10.1002/glia.23847
- By:
- Publication type:
- Article
The voltage‐gated potassium channel Kv1.3 is required for microglial pro‐inflammatory activation in vivo.
- Published in:
- Glia, 2018, v. 66, n. 9, p. 1881, doi. 10.1002/glia.23457
- By:
- Publication type:
- Article
Differential Kv1.3, KCa3.1, and Kir2.1 expression in 'classically' and 'alternatively' activated microglia.
- Published in:
- Glia, 2017, v. 65, n. 1, p. 106, doi. 10.1002/glia.23078
- By:
- Publication type:
- Article
Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) causes seizure activity in larval zebrafish via antagonism of γ-aminobutyric acid type A receptor α1β2γ2.
- Published in:
- Archives of Toxicology, 2023, v. 97, n. 5, p. 1355, doi. 10.1007/s00204-023-03475-7
- By:
- Publication type:
- Article
New capsaicin analogs as molecular rulers to define the permissive conformation of the mouse TRPV1 ligand-binding pocket.
- Published in:
- eLife, 2020, p. 1, doi. 10.7554/eLife.62039
- By:
- Publication type:
- Article
Muscle Damage in Dystrophic mdx Mice Is Influenced by the Activity of Ca 2+ -Activated K Ca 3.1 Channels.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 4, p. N.PAG, doi. 10.3390/life12040538
- By:
- Publication type:
- Article
KV1.3 INHIBITION REDUCES AB-INDUCED MICROGLIAL NEUROTOXICITY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P242, doi. 10.1016/j.jalz.2016.06.434
- By:
- Publication type:
- Article
The role of potassium channel Kv1.3 in Aß-induced microglia activation
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Interrogation of the intersubunit interface of the open Hv1 proton channel with a probe of allosteric coupling.
- Published in:
- Scientific Reports, 2015, p. 14077, doi. 10.1038/srep14077
- By:
- Publication type:
- Article
The K<sup>+</sup> Channel K<sub>Ca</sub>3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0085244
- By:
- Publication type:
- Article
The Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel KCa3.1 as a Potential New Target for the Prevention of Allograft Vasculopathy.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081006
- By:
- Publication type:
- Article
Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes.
- Published in:
- PLoS ONE, 2013, v. 8, n. 10, p. 1, doi. 10.1371/journal.pone.0076740
- By:
- Publication type:
- Article
K<sub>Ca</sub>3.1 Channel-Blockade Attenuates Airway Pathophysiology in a Sheep Model of Chronic Asthma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066886
- By:
- Publication type:
- Article
Novel Phenolic Inhibitors of Small/Intermediate-Conductance Ca<sup>2+</sup>-Activated K<sup>+</sup> Channels, KCa3.1 and KCa2.3.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058614
- By:
- Publication type:
- Article
Genetic KCa3.1-Deficiency Produces Locomotor Hyperactivity and Alterations in Cerebral Monoamine Levels.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047744
- By:
- Publication type:
- Article
Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is K<sub>Ca</sub>3.1-dependent.
- Published in:
- Respiratory Research, 2014, v. 15, n. 12, p. 1, doi. 10.1186/s12931-014-0155-5
- By:
- Publication type:
- Article
Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Assessing the Effects of Cytoprotectants on Selective Neuronal Loss, Sensorimotor Deficit and Microglial Activation after Temporary Middle Cerebral Occlusion.
- Published in:
- Brain Sciences (2076-3425), 2019, v. 9, n. 10, p. 287, doi. 10.3390/brainsci9100287
- By:
- Publication type:
- Article
Radiation Increases Functional KCa3.1 Expression and Invasiveness in Glioblastoma.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 279, doi. 10.3390/cancers11030279
- By:
- Publication type:
- Article
Human lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca<sup>2+</sup>-dependent and regulated by K<sub>Ca</sub>3.1 K<sup>+</sup> channels.
- Published in:
- Fibrogenesis & Tissue Repair, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13069-015-0022-0
- By:
- Publication type:
- Article
Characterisation of the human voltage-gated potassium channel gene, KCNA7, a candidate gene for inherited cardiac disorders, and its exclusion as cause of progressive familial heart block I (PFHBI).
- Published in:
- European Journal of Human Genetics, 2002, v. 10, n. 1, p. 36, doi. 10.1038/sj.ejhg.5200739
- By:
- Publication type:
- Article
SKA-31, a novel activator of SKCa and IKCa channels, increases coronary flow in male and female rat hearts.
- Published in:
- Cardiovascular Research, 2013, v. 97, n. 2, p. 339, doi. 10.1093/cvr/cvs326
- By:
- Publication type:
- Article
Ca<sup>2+</sup>-Activated K<sup>+</sup> Channel-3.1 Blocker TRAM-34 Attenuates Airway Remodeling and Eosinophilia in a Murine Asthma Model.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2013, v. 48, n. 2, p. 212, doi. 10.1165/rcmb.2012-0103OC
- By:
- Publication type:
- Article
The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2016, v. 36, n. 12, p. 2146, doi. 10.1177/0271678X15611434
- By:
- Publication type:
- Article
The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2011, v. 31, n. 12, p. 2363, doi. 10.1038/jcbfm.2011.101
- By:
- Publication type:
- Article
Vascular dysfunctions in the isolated aorta of double-transgenic hypertensive mice developing aortic aneurysm.
- Published in:
- Pflügers Archiv: European Journal of Physiology, 2015, v. 467, n. 9, p. 1945, doi. 10.1007/s00424-014-1644-6
- By:
- Publication type:
- Article
Preserved regulation of renal perfusion pressure by small and intermediate conductance K channels in hypertensive mice with or without renal failure.
- Published in:
- Pflügers Archiv: European Journal of Physiology, 2015, v. 467, n. 4, p. 817, doi. 10.1007/s00424-014-1542-y
- By:
- Publication type:
- Article
Conditional KCa3.1-transgene induction in murine skin produces pruritic eczematous dermatitis with severe epidermal hyperplasia and hyperkeratosis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0222619
- By:
- Publication type:
- Article
Enhancement of Endothelial KCa Channel Activity as a Novel Strategy to Oppose Atherosclerosis.
- Published in:
- FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R2908
- By:
- Publication type:
- Article
Enhancement of Endothelial KCa Channel Activity as a Novel Strategy to Oppose Atherosclerosis.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.02504
- By:
- Publication type:
- Article
Kv1.3 channel-blocking immunomodulatory pep tides from parasitic worms: implications for autoimmune diseases.
- Published in:
- FASEB Journal, 2014, v. 28, n. 9, p. 3952, doi. 10.1096/fj.14-251967
- By:
- Publication type:
- Article
KCa3.1 in the early stages of ischemic stroke (893.19).
- Published in:
- FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.893.19
- By:
- Publication type:
- Article
The vasoconstrictor agent phenylephrine selectively modulates endothelium‐ vs. smooth muscle‐mediated inhibition of myogenic tone in rat cremaster arteries (677.5).
- Published in:
- FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.677.5
- By:
- Publication type:
- Article
A pharmacologic activator of endothelial KCa channels improves coronary function in the hearts of type 2 diabetic rats (1078.10).
- Published in:
- FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.1078.10
- By:
- Publication type:
- Article
Positive KCa channel gating modulators with selectivity for KCa3.1 (1057.6).
- Published in:
- FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.1057.6
- By:
- Publication type:
- Article
ATP-evoked intracellular Ca<sup>2+</sup> transients shape the ionic permeability of human microglia from epileptic temporal cortex.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Development of Tetramethylenedisulfotetramine (TETS) Hapten Library: Synthesis, Electrophysiological Studies, and Immune Response in Rabbits.
- Published in:
- Chemistry - A European Journal, 2017, v. 23, n. 35, p. 8466, doi. 10.1002/chem.201700783
- By:
- Publication type:
- Article
The seizure‐inducing plastic explosive RDX inhibits the α1β2γ2 GABA<sub>A</sub> receptor.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 5, p. 600, doi. 10.1002/acn3.51536
- By:
- Publication type:
- Article
The potassium channel Kv1.3 as a therapeutic target for immunocytoprotection after reperfusion.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 10, p. 2070, doi. 10.1002/acn3.51456
- By:
- Publication type:
- Article
Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2019, v. 6, n. 4, p. 723, doi. 10.1002/acn3.754
- By:
- Publication type:
- Article